Ian M. Burr Division of Pediatric Endocrinology and Diabetes

Team members involved in the study include, from left, Melissa Hilmes, MD, Daniel Moore, MD, PhD, Alvin Powers, MD, Jon Williams, PhD, and Jack Virostko, PhD. (photo by Jessica Kimber)
August 27, 2021

Study proves standardized protocol can support reliable MRI use for multisite pancreatic research

Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software at different geographic locations.

By Jill Clendening
November 3, 2020

New treatment for a rare obesity

Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity.

By Bill Snyder
June 9, 2019

Study drug delays type 1 diabetes in high risk children and adults

Drug delays onset of type 1 diabetes by two years

By Craig Boerner
Team members involved in the study include, from left, Melissa Hilmes, MD, Daniel Moore, MD, PhD, Alvin Powers, MD, Jon Williams, PhD, and Jack Virostko, PhD. (photo by Jessica Kimber)
April 25, 2019

Study expands insight on shrinking pancreas in type 1 diabetes

Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) have discovered a progressive decline in pancreas volume over a one-year period in children and adolescents with newly diagnosed Type 1 diabetes.

By Jill Clendening
September 13, 2018

Healthy antibodies reverse diabetes

Vanderbilt researchers have discovered that IgM-type antibodies appear to play a protective role to prevent the development of type 1 diabetes — and that purified IgM antibodies can reverse the disease.

By Leigh MacMillan
June 22, 2017

Study uses child’s own immune system against type one diabetes

Eighteen-year-old Grace Long had just been accepted at the renowned United States Naval Academy, with plans to become a nuclear engineering officer. Then, she learned she had type 1 diabetes, an immediate disqualifier for military service.

By Jill Clendening
November 17, 2016

Stem cells promote tolerance

Blood-forming stem cells play a role in immune tolerance and acceptance of organ transplants, Vanderbilt researchers have discovered.
By Leigh MacMillan
June 2, 2016

VUMC researchers seek to crack the code of neonatal sepsis

Sepsis, an exaggerated and overwhelming inflammatory response to infection, is a major worldwide killer of babies in the first four weeks of life (neonatal period).
By Bill Snyder
January 14, 2016

New tool in fight against pediatric diabetic retinopathy

The Children’s Diabetes Program at Monroe Carell Jr. Children’s Hospital at Vanderbilt recently unveiled its latest tool in helping to prevent diabetic retinopathy, the leading cause of acquired blindness in the United States.
By Jessica Pasley
October 1, 2015

Tolerating a transplant

A new genetic model has generated new strategies for promoting tolerance to transplants – and improving long-term transplant outcomes – in the background of autoimmune disease.
By Leigh MacMillan
September 10, 2015

Diabetes trial targets body’s ability to produce insulin

Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment.
By VUMC News and Communications
August 13, 2015

Simmons strives to make a difference in children’s lives

Jill Simmons, M.D., encounters medical mysteries that have the makings of a science fiction film or novel.
By Christina Echegaray
April 9, 2015

Steeplechase again set to saddle up for Children’s Hospital

Nashville and Monroe Carell Jr. Children’s Hospital at Vanderbilt are gearing up for another year of one of America’s premier horse racing events, the Iroquois Steeplechase, now in its 74th year.
By Christina Echegaray
1 2 3